Asked by: Nick Fletcher (Conservative - Don Valley)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps her Department plans to take to improve early diagnosis rates for prostate cancer.
Answered by Andrew Stephenson
The UK National Screening Committee (UK NSC) does not currently recommend screening for prostate cancer as the current test, the Prostate Specific Antigen test, does not meet the required accuracy for use in a national screening programme. Current methods offer insufficient benefit in relation to harms caused by overdiagnosis, which may lead to invasive investigative procedures and unnecessary treatment, to warrant roll out as an organised screening programme. The UK NSC is due to review prostate cancer again in 2024 and will consider new evidence published between the two reviews.
In November 2023 we announced we will be funding a £42 million screening trial with Prostate Cancer UK to find ways of detecting country’s most common male cancer earlier. The first-of-its-kind trial, called TRANSFORM, will use innovative screening methods like magnetic resonance imaging (MRI) scanning to detect prostate cancer, and it will see hundreds of thousands of men across the country participating.
Steps have been taken to use enhanced testing to increase early diagnosis rates for prostate cancer; NHS England have streamlined cancer pathways, including implementing a best timed prostate cancer diagnostic pathway so that those suspected of prostate cancer receive a multi-parametric MRI scan first, which ensures only those men most at-risk undergo an invasive biopsy. Furthermore, to boost early diagnosis NHS England is supporting three pilots, including the Man Van as part of the COVID-19 catch up cancer initiative. The Man Van was launched in March 2022 to provide free health checks for men and boost early diagnosis of prostate cancer.
In addition, backed by £2.3 billion capital funding, the department is expanding diagnostic capacity across the National Health Service by rolling out more Community Diagnostic Centres (CDCs), delivering vital tests, scans and checks. With 150 CDCs open already and up to 160 set to open by March 2025, these offer millions of patients the chance to access quicker, more convenient checks outside of hospitals, with capacity prioritised for cancer. This is contributing to the elective recovery delivery plan ambition for 75% of patients urgently referred by their general practice for suspected cancer to receive a diagnosis or have cancer ruled out within 28 days.
Asked by: Mark Eastwood (Conservative - Dewsbury)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if she will make an estimate of the average time taken to diagnose ovarian cancer (a) in West Yorkshire and (b) nationally.
Answered by Andrew Stephenson
The most recent data for the diagnosis of ovarian cancer in West Yorkshire shows a 23-day average from an urgent referral for suspected cancer to diagnosis. This data is based on median values, taken across a twelve-month period from November 2022 to October 2023 inclusive.
Patients diagnosed with ovarian cancer can be diagnosed via other routes, such as when presenting as an emergency case in an unplanned care setting, or as an incidental finding when referred for another elective condition or suspected abnormality, either urgently or non-urgently. Data for these alternative presentation routes in the format requested is not held.
Asked by: Andrew Rosindell (Conservative - Romford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps her Department is taking to help improve the diagnosis (a) rates and (b) treatments for ovarian cancer in (i) England and (ii) Romford constituency.
Answered by Andrew Stephenson
Improving the diagnosis rate and treatment for all cancers including for ovarian cancer, is a priority for this Government. The Department is working with NHS England and is taking steps across England to increase diagnosis rates, including setting stretching ambitions, supporting general practitioners (GPs) in referring patients, expanding diagnostic capacity and enabling more precise diagnosis through technology. These steps and actions apply in Romford as across England.
To encourage people to see their general practitioner if they notice symptoms that could be cancer, NHS England runs the ‘Help Us, Help You’ campaigns, which address the barriers that deter patients from accessing the National Health Service. NHS England is currently running a ‘Help us Help you’ campaign highlighting the abdominal and urological symptoms of cancer, including ovarian cancer, and addressing the barriers that stop people from accessing services in the NHS.
NHS England introduced the Faster Diagnosis Standard (FDS) which aims to ensure patients have cancer diagnosed or ruled out within 28 days of urgent referral from a GP or screening services with a 75% standard ambition. To achieve the FDS, NHS England has implemented ‘non-specific symptom pathways’ for patients who have symptoms that do not align to a particular type of tumour, including for non-specific symptoms of pancreatic cancer.
Further to this, the Department has committed to £2.3 billion of capital funding to expanding diagnostic capacity across the NHS by rolling out more community diagnostic centres, delivering vital tests, scans and checks, including for ovarian cancer.
The Department invests in health research through the National Institute for Health and Care Research (NIHR). NIHR has funded six research projects into screening for ovarian cancer since 2018, with a combined total funding value of £3.8 million, including looking at the impact and effectiveness of different kinds of testing and screening and effectiveness of treatment options. The overall goal is to improve diagnosis and treatment to improve patient outcomes.
Mentions:
1: Baroness Merron (Lab - Life peer) cancer beyond five years. - Speech Link
2: Baroness Bloomfield of Hinton Waldrist (Con - Life peer) and more recently with Breast Cancer Now. - Speech Link
3: Lord Evans of Rainow (Con - Life peer) and more recently with Breast Cancer Now. - Speech Link
4: Lord Patel (XB - Life peer) We know that early diagnosis achieves the best results for all cancers, yet we are woefully low in the - Speech Link
5: Baroness Merron (Lab - Life peer) I can say to your Lordships’ House that this Government intend to transform the NHS from a late-diagnosis - Speech Link
6: Baroness Ritchie of Downpatrick (Lab - Life peer) screening age to 40, to include for diagnosis those with triple-negative breast cancer, because many - Speech Link
Aug. 20 2024
Source Page: Ovarian cancer QS updateFound: Ovarian cancer QS update
Asked by: Mark Pritchard (Conservative - The Wrekin)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to improve the early (a) diagnosis and (b) treatment of pancreatic cancer.
Answered by Andrew Gwynne - Parliamentary Under-Secretary (Department of Health and Social Care)
NHS England is delivering a range of interventions that are expected to improve early diagnosis and treatment for patients with suspected and diagnosed pancreatic cancer. For early diagnosis, this includes providing a route into pancreatic cancer surveillance for those patients at inherited high-risk, to identify lesions before they develop into cancer, and diagnose cancers sooner. New pathways are being created to support faster referral routes for people with non-specific symptoms that could be linked to a range of cancer types. General practice direct access to diagnostic tests is also being increased.
To improve the consistency of access to treatments, NHS England is funding an audit into pancreatic cancer which aims to stimulate improvements in cancer treatment and outcomes. The Royal College of Surgeons began work on this audit in October 2022, and the first report is expected in October 2024.
NHS England’s Getting it Right First Time programme has also appointed a team of five specialist clinicians to lead a national review into services for pancreatic cancer patients in England. The workstream supports the delivery of the Optimal Care Pathway, a Pancreatic Cancer UK-led initiative which has brought together 300 health professionals and people affected to agree on how standards of diagnosis, treatment, and care of those patients with pancreatic cancer and their families can be improved, as well as gathering examples of good practice to share.
Nov. 01 2011
Source Page: Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. [Published article.] 12 p.Found: Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International
Asked by: Jim Shannon (Democratic Unionist Party - Strangford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if he will make an assessment of the adequacy of diagnosis rates for pancreatic cancer in the last 12 months.
Answered by Andrew Gwynne - Parliamentary Under-Secretary (Department of Health and Social Care)
We will improve cancer survival rates by hitting all National Health Service cancer waiting time targets within five years, including for pancreatic cancer. We know that pancreatic cancer is difficult to diagnose due to the non-specific nature of its symptoms. To improve diagnosis and outcomes, NHS England is delivering a range of interventions including implementing non-specific symptom pathways for patients who have symptoms that do not align to a single tumour type, as is often the case with pancreatic cancer. 96 pathways are in place, and more are being introduced. NHS England is also increasing general practice direct access to diagnostic tests, alongside providing a route into pancreatic cancer surveillance for those at inherited high-risk, to identify lesions before they develop into cancer and diagnose cancers sooner.
The most recent Faster Diagnosis Standard performance for upper gastrointestinal cancers, including oesophageal cancer, stomach cancer, small bowel cancer, pancreatic cancer, liver cancer and cancers of the biliary system, is 76% against the 75% standard for May 2024.
Jul. 11 2011
Source Page: Tables showing count of finished consultant episodes with a procedure or intervention where the primary diagnosis was skin cancer by specified age bands and PCT of treatment for 1997/98 to 2009/10. 38 p.Found: Tables showing count of finished consultant episodes with a procedure or intervention where the primary diagnosis
Aug. 20 2024
Source Page: Ovarian cancer QS updateFound: Ovarian cancer QS update